Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AC Immune (ACIU) Revenue: 2014-2025

Historic Revenue for AC Immune (ACIU) over the last 12 years, with Sep 2025 value amounting to $28.7 million.

  • AC Immune's Revenue fell 96.01% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 82.53%. This contributed to the annual value of $28.7 million for FY2025, which is N/A change from last year.
  • As of FY2025, AC Immune's Revenue stood at $28.7 million, which was down 8.02% from $31.2 million recorded in FY2024.
  • AC Immune's Revenue's 5-year high stood at $31.2 million during FY2024, with a 5-year trough of $744,157 in FY2021.
  • Moreover, its 3-year median value for Revenue was $28.7 million (2025), whereas its average is $25.5 million.
  • In the last 5 years, AC Immune's Revenue slumped by 95.64% in 2021 and then skyrocketed by 448.89% in 2022.
  • Yearly analysis of 5 years shows AC Immune's Revenue stood at $744,157 in 2021, then surged by 448.89% to $4.1 million in 2022, then surged by 308.51% to $16.7 million in 2023, then spiked by 86.83% to $31.2 million in 2024, then reached $28.7 million in 2025.